Fort Worth, Texas 76107 as a signal for cardiac hypertrophy. In response to myoParke-Davis cyte stretch or increased loads on working heart prepa-2800 Plymouth Road rations, intracellular Ca 2ϩ concentrations increase (MarAnn Arbor, Michigan 48105 ban et al., 1987; Bustamante et al., 1991; Hongo et al., 1995) , consistent with a role of Ca 2ϩ in coordinating physiologic responses with enhanced cardiac output. A Summary variety of humoral factors, including angiotensin II (AngII), phenylephrine (PE), and endothelin-1 (ET-1), In response to numerous pathologic stimuli, the myowhich induce the hypertrophic response in cardiomyocardium undergoes a hypertrophic response characcytes (Karliner et al., 1990; Sadoshima and Izumo, 1993 ; terized by increased myocardial cell size and activation Sadoshima et al., 1993; Leite et al., 1994) , also share of fetal cardiac genes. We show that cardiac hypertrothe ability to elevate intracellular Ca 2ϩ concentrations. phy is induced by the calcium-dependent phosphatase Hypertrophic stimuli result in reprogramming of gene calcineurin, which dephosphorylates the transcription expression in the adult myocardium, such that genes factor NF-AT3, enabling it to translocate to the nuencoding fetal protein isoforms like ␤-myosin heavy cleus. NF-AT3 interacts with the cardiac zinc finger chain (MHC) and ␣-skeletal actin are up-regulated, transcription factor GATA4, resulting in synergistic acwhereas the corresponding adult isoforms, ␣-MHC and tivation of cardiac transcription. Transgenic mice that ␣-cardiac actin, are down-regulated. The natriuretic express activated forms of calcineurin or NF-AT3 in peptides, atrial natriuretic factor (ANF), and b-type natrithe heart develop cardiac hypertrophy and heart failuretic peptide (BNP), which decrease blood pressure by ure that mimic human heart disease. Pharmacologic vasodilation and natriuresis, are also rapidly up-reguinhibition of calcineurin activity blocks hypertrophy in lated in the heart in response to hypertrophic signals vivo and in vitro. These results define a novel hypertro-(reviewed in Komuro and Yazaki, 1993) . The mechaphic signaling pathway and suggest pharmacologic nisms involved in coordinately regulating these cardiac approaches to prevent cardiac hypertrophy and heart genes during hypertrophy are unknown, although bindfailure.
ing sites for several transcription factors, including serum response factor (SRF), TEF-1, AP-1, and Sp1, are Introduction important for activation of fetal cardiac genes in response to hypertrophy ; Cardiac hypertrophy is an adaptive response of the heart Sadoshima et al., 1993; Kariya et al., 1994; Karns et al. , to virtually all forms of cardiac disease, including those 1995; Kovacic-Milivojevic et al., 1996) . Most recently, the arising from hypertension, mechanical load, myocardial cardiac-restricted zinc finger transcription factor GATA4 infarction, cardiac arrhythmias, endocrine disorders, and has also been shown to be required for transcriptional genetic mutations in cardiac contractile protein genes.
activation of the genes for Ang II type 1a receptor and While the hypertrophic response is initially a compen-␤-MHC during hypertrophy (Herzig et al., 1997 ; Hasesatory mechanism that augments cardiac output, susgawa et al., 1997; reviewed in Molkentin and Olson, tained hypertrophy can lead to dilated cardiomyopathy, 1997). heart failure, and sudden death. In the United States, A number of intracellular signaling pathways have been implicated in transduction of hypertrophic stimuli. For example, occupancy of the cell surface receptors # To whom correspondence should be addressed.
for AngII, PE, and ET-1 leads to activation of phospholipase C, resulting in the production of diacylglycerol and inositol triphosphate, which in turn results in mobilization of intracellular Ca 2ϩ and activation of protein kinase C (PKC) Yamazaki et al., 1996; Zou et al., 1996) . There is also evidence that the Ras and mitogen-activated protein (MAP) kinase pathways are transducers of hypertrophic signals (Thorburn et al., 1993; reviewed in Force et al., 1996) . The extent to which these signaling pathways are coordinated during cardiac hypertrophy is unknown. However, all of these pathways are associated with an increase in intracellular Ca 2ϩ , consistent with a central regulatory role of Ca 2ϩ in coordinating the activities of multiple hypertrophic signaling pathways. In B and T cells, the Ca 2ϩ , calmodulin-dependent phosphatase calcineurin has been shown to link intracellular signaling pathways that result in elevation of intracellular Ca 2ϩ with activation of the immune response. Calcineurin regulates immune response genes through dephosphorylation of a family of transcription factors known as NF-ATs (nuclear factors of activated T cells) (reviewed in . Once dephosphorylated by calcineurin, NF-AT transcription factors translocate to the nucleus and directly activate immune response genes (Flanagan et al., 1991; Loh et al., 1996a Loh et al., , 1996b . The immunosuppressant drugs cyclosporin A (CsA) and FK 506 suppress the immune response by inhibiting calcineurin's ability to activate NF-AT transcription factors (Shaw et al., 1995; Loh et al., 1996b) .
Here we show that the myocardium utilizes a calcineurin-dependent pathway to activate the transcrip- the subsequent induction of fetal cardiac genes via a (B) Amino acids 522-902 of NF-AT3 were fused in-frame to the GAL4 DNA-binding domain (DBD) and used as bait in a two-hybrid assay combinatorial mechanism involving its direct interaction in transfected 10T1/2 cells. with GATA4. Transgenic mice that express activated forms of calcineurin or NF-AT3 in the heart develop cardiac hypertrophy that progresses to dilated cardiofor GATA4 in the heart. The GATA4 bait consisted of myopathy, with interstitial fibrosis, congestive heart amino acids 130-409 fused in-frame to the yeast GAL4 failure, and sudden death. CsA and FK 506 block the protein ( Figure 1A ). This region of GATA4 encompasses morphologic and molecular responses of primary carthe two zinc fingers and most of the carboxyl terminus diomyocytes to Ang II and PE, indicating that calcineurin but lacks the amino-terminal transcription activation dois a component of the signaling pathways whereby these main, and therefore does not activate transcription on factors induce hypertrophy. Moreover, CsA administraits own in yeast. Screening of a 10.5-day mouse embryo tion can prevent cardiac hypertrophy and associated cDNA library resulted in the identification of numerous pathology in calcineurin transgenic mice. These results GATA4-interacting factors, one of which was NF-AT3. define a novel signaling pathway that couples hypertro-
The other GATA4-interacting factors identified in this phic signals at the cell membrane to changes in cardiac screen will be described elsewhere. gene expression and suggest opportunities for pharma-NF-AT3 is a member of a multigene family containing cologic intervention into cardiac hypertrophy and heart four members, NF-ATc, NF-ATp, NF-AT3, and NF-AT4 failure.
( McCaffrey et al., 1993; Northrop et al., 1994; Ho et al., 1995; Hoey et al., 1995; Masuda et al., 1995; Park et al., Results 1996) . These factors bind the consensus DNA sequence GGAAAAT as monomers or dimers through a Rel homolInteraction between NF-AT3 and GATA4 ogy domain (RHD) (Rooney et al., 1994; Hoey et al., Our initial interest was to identify proteins, using the yeast two-hybrid system, that might act as cofactors 1995). Three of the NF-AT genes are restricted in their (A) NF-AT3 with a Flag epitope tag and GATA4, as indicated, were translated in a rabbit reticulocyte lysate in the presence of 35 S-methionine. Anti-Flag antibody was then used for coimmunoprecipitation assays. Proteins were resolved by SDS-PAGE. Lanes 1 and 2 show the in vitro translation products. Lanes 3-5 show the coimmunoprecipitations. The anti-Flag antibody selectively immunoprecipitates NF-AT3 (lane 3) but does not recognize GATA4 (lane 4). However, when NF-AT3 is mixed with GATA4, GATA4 is coimmunoprecipitated (asterisk in lane 5). (B) The domain of GATA4 that interacts with NF-AT3 was mapped by translating NF-AT3-Flag with a series of GATA4 deletion mutants (shown in [C]), followed by coimmunoprecipitation. Even-numbered lanes show the GATA4 or GATA6 (lane 14) deletion mutants loaded directly on the gel. The other lanes contain the indicated GATA4 or GATA6 (lane 15) deletion mutants plus NF-AT3 and were immunoprecipitated with anti-Flag antibody. All GATA4 deletion mutants except 80-441/d265-294, which lacks the second zinc finger, were coimmunoprecipitated. A GATA6 deletion mutant containing the two zinc fingers was also coimmunoprecipitated with NF-AT3. expression to T cells and skeletal muscle, whereas NF-1A). The region of NF-AT3 recovered from the yeast twohybrid screen extended from amino acid 522, which is AT3 is expressed in a variety of tissues including the heart (Hoey et al., 1995) .
near the middle of the Rel homology domain, to the carboxyl terminus. Given the ability of NF-AT factors to mediate changes in gene expression in response to Ca 2ϩ signaling in T The specificity of interaction between GATA4 and NF-AT3 was tested by retransforming yeast with the rescued cells, we were especially interested in the finding that GATA4, a known effector of cardiac gene expression, NF-AT3-GAL4 activation domain plasmid and various GAL4 DNA-binding domain bait plasmids. In this assay, and NF-AT3 were able to interact. This interaction suggested a potential mechanism for coupling Ca 2ϩ signal-NF-AT3 was also found to interact with residues 133-265 of GATA5, which encompass only the zinc finger DNAing to cardiac transcription, as is known to occur during cardiac hypertrophy.
binding domain. However, NF-AT3 did not interact with the basic helix-loop-helix protein E12 or with the GAL4 NF-AT3 is a 902-amino acid protein with a regulatory domain at its amino terminus that mediates nuclear DNA-binding domain alone (data not shown).
To validate further the interaction between GATA4 translocation and the Rel homology domain near its carboxyl terminus that mediates DNA binding ( Figure  and NF-AT3, the rescued NF-AT3 cDNA fragment was (A) Primary rat cardiomyocytes were transiently transfected with a CAT reporter gene linked to the BNP 5Ј-flanking region and expression vectors encoding NF-AT3, activated calcineurin, or GATA4, as indicated. Forty-eight hours later, cells were harvested and CAT activity was determined. In the lane labeled Ϫ927 site mutant, a BNP-CAT reporter gene, in which the NF-AT3 site at Ϫ927 was mutated, was used.
(B) 32 P-labeled oligonucleotide probes corresponding to the potential NF-AT binding sites from the IL-2 promoter and from Ϫ927, Ϫ327, and Ϫ27 bp 5Ј of the BNP gene were used in gel mobility shift assays with unprogrammed reticulocyte lysate (lanes 1-4) or in vitro translated NF-AT3 (lanes 5-8). Only the IL-2 and BNP-927 probes yielded a specific DNA-protein complex. (C) A 32 P-labeled oligonucleotide probe corresponding to the Ϫ927 BNP site was used in gel mobility shift assays with protein extracts from neonatal rat cardiomyocytes. Multiple specific complexes were generated (lane 1), which were competed by unlabeled cognate site (lane 2), but not by an unrelated E-box oligonucleotide (lane 3). Addition of NF-AT3 antibody eliminated the major DNA-protein complex and created a minor ternary complex (asterisk in lane 5), whereas nonimmune rabbit serum had no effect (lane 4). Free probe was electrophoresed off the bottom of the gel in both experiments.
fused to the GAL4 DNA-binding domain and tested for the two zinc fingers and NLS, interacted with NF-AT3 as efficiently as full-length GATA4 ( Figure 2B , lane 11). its ability to interact with full-length GATA4 in transfected mammalian cells. As a reporter plasmid, we used
Residues 239-441 of GATA4, which extend from the second zinc finger to the C terminus, also interacted with pG5E1bCAT, which contains five tandem GAL4 DNAbinding sites upstream of the minimal E1b promoter NF-AT3 (lane 7), whereas an internal deletion mutant lacking the second zinc finger (80-441/d265-294) did linked to CAT. This reporter was not significantly activated by either GAL4-NF-AT3 or GATA4 alone but was not (lane 13). These experiments demonstrated that the second zinc finger of GATA4 was essential for interacstrongly activated by the two factors together in 10T1/2 fibroblasts ( Figure 1B ), as well as in primary neonatal tion with NF-AT3, whereas the N terminus, the first zinc finger, and the C terminus were unimportant for this rat cardiomyocytes (data not shown). Full-length NF-AT3 also interacted with the GAL4-GATA4 bait in the interaction ( Figure 2C ). Also of note, the zinc finger region (amino acids 130-350) of GATA6 was immunopremammalian transfection assay (data not shown).
cipitated with NF-AT3 (lane 15). We also tested a deletion mutant of NF-AT3 that Mapping the Protein Determinants of GATA4-NF-AT3 Interaction encompassed only the Rel homology domain, residues 404-694. This region was sufficient to interact with To define further the interaction between GATA4 and NF-AT3, we tested whether interactions between the GATA4 ( Figure 2D , lane 5). Together, these results indicated that the Rel homology region of NF-AT3 contained corresponding 35 S-methionine-labeled in vitro translation products could be detected. Cotranslation of fulldeterminants that mediate interaction with the second zinc finger of GATA4. length GATA4 with the NF-AT3 deletion mutant containing residues 522-902 fused to a Flag epitope at the C terminus, followed by immunoprecipitation with antiSynergistic Activation of the BNP Gene by GATA4 and NF-AT3 Flag antibody and SDS-PAGE, showed that the two proteins coimmunoprecipitated ( Figure 2A , lane 5). The antiTo begin to investigate whether the GATA4-NF-AT3 interaction had a functional role in cardiac gene expresFlag antibody did not immunoprecipitate GATA4 in the absence of NF-AT3-Flag (lane 4). sion, we tested the ANF, BNP, and cardiac troponin I promoters, which are up-regulated during hypertrophy, To map the determinants of this interaction more precisely, we tested a series of GATA4 deletion mutants for their responsiveness to these factors in transfected neonatal rat cardiomyocytes. The BNP promoter showed for the ability to be coimmunoprecipitated with NF-AT3-Flag. Residues 181-328 of GATA4, which encompass a dramatic response and was therefore analyzed further. (A-F) Primary rat cardiocytes in serum-free medium were stimulated with AngII (10 nM) or PE (10 M) for 72 hr. Cells were then fixed and stained with anti-␣-actinin antibody to reveal sarcomeres and Hoechst stain to reveal nuclei. CsA (500 ng/ml) was added to one set of cultures at the time of AngII addition.
(G) Total RNA was isolated from primary cardiocyte cultures treated with AngII in the presence or absence of CsA as in (A) and analyzed for expression of GAPDH and ANF transcripts by dot blot.
(H) Primary rat cardiomyocytes were transiently transfected with an NF-AT-dependent luciferase reporter gene. Cells were then treated with AngII or PE in the presence or absence of CsA, as described above. Fortyeight hours later, cells were harvested and luciferase activity was determined.
For these experiments, we also used a cDNA expression oligonucleotide probes corresponding to these sequences, we used gel mobility shift assays to test for plasmid encoding a constitutively active form of the calcineurin catalytic A subunit lacking the C-terminal binding to in vitro translated NF-AT3 protein generated in a rabbit reticulocyte lysate. The putative site at Ϫ927 autoinhibitory domain (O'Keefe et al., 1992) . This calcineurin mutant functions as a Ca 2ϩ -independent phosbound NF-AT3 as avidly as the consensus NF-AT site from the IL-2 promoter, whereas no binding was dephatase but retains sensitivity to CsA and FK506. As shown in Figure 3A , the BNP promoter was activated tected to the Ϫ327 or Ϫ27 sites ( Figure 3B ). To confirm that NF-AT3 from cardiomyocytes could greater than 100-fold in the presence of GATA4, NF-AT3, and calcineurin. GATA4 alone was also able to also bind the Ϫ927 site from the BNP promoter, we used cardiac protein extracts in a gel mobility shift assay with activate this promoter, as reported previously (Grepin et al., 1994) , but the extent of activation was less than the Ϫ927 site as a probe. Cardiac extract gave rise to multiple complexes that could be eliminated in the one-tenth that when NF-AT3 and calcineurin were also present. Since GATA4 and NF-AT3 are expressed in presence of an excess of the same unlabeled oligonucleotide or by a sequence corresponding to the NF-AT neonatal rat cardiomyocytes, it seems they are limiting in this type of transfection assay, making it necessary site in the IL-2 promoter (data not shown), but not by nonspecific sequences ( Figure 3C ). The cardiomyocyte to express the exogenous proteins to see the maximal response of the BNP promoter.
complex could also be largely eliminated using an NF-AT3-specific antibody (lane 5). Given the dramatic responsiveness of the BNP promoter to NF-AT3, we examined the 1800 bp promoter
To determine whether the Ϫ927 site was required for transcriptional activation by NF-AT3, we mutated this region used in the above transfection assays for potential NF-AT consensus binding sites (GGAAAAT). Three site and found that the mutant promoter was insensitive to NF-AT3 ( Figure 3A ). These results demonstrate that sequences related to this site were identified at Ϫ927 (TGGAAAACAA), Ϫ327 (TGGAAAAGGC), and Ϫ27 (AGG the BNP promoter is a direct transcriptional target for synergistic activation by GATA4 and NF-AT3 in cardio-ATAAAAG). The Ϫ27 site also binds GATA4 and is required for BNP expression (Grepin et al., 1994). Using myocytes. Heart weights were determined and are expressed as the relative weight of the transgenic heart compared to nontransgenic litter mates. Ages of mice that are still alive are shown in parentheses as of 2/18/98. 37 and 39 were founder transgenics and, mice designated as 37-and 39-were their offspring. ND, not determined.
CsA and FK506 Inhibit the Hypertrophic Induction of Cardiac Hypertrophy In Vivo Effects of AngII and PE by Activated Calcineurin Exposure of primary cardiomyocytes to AngII and PE
To determine whether the calcineurin signal transducresults in an increase in intracellular Ca 2ϩ and a hypertrotion pathway could also operate in the myocardium in phic response. To determine whether the hypertrophic vivo, we generated transgenic mice that expressed the response of cardiomyocytes to these agonists was meconstitutively active form of the calcineurin catalytic diated by calcineurin, we exposed neonatal rat cardiosubunit in the heart, using the ␣-MHC promoter to drive myocytes to AngII (10 nM) or PE (10 M) in the presence expression. Previous studies have shown that this carand absence of CsA or FK 506. Cardiomyocytes demondiac-specific promoter is active in the ventricular chamstrated a dramatic increase in size and sarcomeric asbers primarily after birth (Jones et al., 1994) . A total of ten sembly after 72 hr of exposure to AngII or PE (Figures independent founder transgenic mice were generated, 4B and 4E). In the presence of CsA (Figures 4C and 4F) which contained between 2 and 68 copies of the ␣-MHCor FK 506 (data not shown), the response to AngII was calcineurin transgene (Table 1) . completely abolished and the response to PE was draEvery calcineurin transgenic mouse analyzed showed matically reduced. a dramatic increase in heart size relative to nontransTo determine whether changes in cardiomyocyte gene genic littermates. The heart-to-body weight ratio averexpression in response to AngII were also controlled by aged 2-to 3-fold greater in the calcineurin transgenics a calcineurin-dependent signaling pathway, we examcompared to control littermates, even as early as 18 ined by dot blot assay the expression of ANF mRNA in days postnatally ( Figure 5 , Table 1 ). Histological analysis cardiomyocytes treated with AngII in the presence and showed concentric hypertrophy wherein the cross secabsence of CsA. Exposure to AngII resulted in a 15-fold tional areas of the ventricular walls and interventricular increase in ANF mRNA, which was completely blocked septum were dramatically increased ( Figure 5C ). The by CsA ( Figure 4G ). GAPDH mRNA was measured as a left ventricle was most affected, but the right ventricle control. Together, these morphologic and molecular and the atrial chambers were also enlarged. In contrast data demonstrate that the AngII and PE hypertrophic to the well-organized, striated musculature of the normal signaling pathways are CsA-/FK 506-sensitive and thereventricular wall, cardiomyocytes from the calcineurin fore involve calcineurin activation.
transgenic hearts were disorganized and obviously hyIf NF-AT activation mediates Ca 2ϩ -dependent hyperpertrophic ( Figures 5D and 5E ). The hypertrophic cardiotrophic signaling, then AngII and PE would be expected myocytes often had dramatic karyomegaly. Measureto induce NF-AT activity. To test this, we transfected ment of cross sectional areas of myocytes within the left primary rat cardiomyocytes with an NF-AT-dependent ventricular wall showed a greater than 2-fold increase in luciferase reporter containing three copies of the NFcalcineurin transgenics compared to controls (data not AT consensus sequence linked to the thymidine kinase shown). minimal promoter. In the presence of AngII (10 nM) or
In humans, cardiac hypertrophy frequently progresses PE (10 M), reporter gene expression was up-regulated to ventricular dilatation, heart failure, and sudden death. (Figure 4H ). This up-regulation was completely abolSimilarly, in calcineurin transgenic mice, we observed ished in the presence of CsA or FK 506, supporting the dilatation of the ventricular chambers with increasing conclusion that AngII and PE activate NF-AT through a calcineurin-dependent signal transduction pathway.
age ( Figures 5F and 5G ). Calcineurin transgenic mice were also highly susceptible to sudden death. This ocdown-regulated during heart failure, as the failing myocardium exhibits defective Ca 2ϩ handling (Schwinger et curred spontaneously, as well as during handling or anesthesia. The mice that died from sudden death showed al., 1995); both transcripts were decreased in calcineurin transgenics. There was no significant change in GAPDH right and left ventricular dilatation indicative of heart failure. Histology of the lungs also revealed extensive expression. perivascular edema and intraalveolar macrophages containing red blood cells (data not shown), findings consisInduction of Cardiac Hypertrophy In Vivo tent with heart failure. One of the hallmarks of heart by Activated NF-AT3 failure is fibrosis of the ventricular wall. The hearts of While activation of NF-AT3 proteins is a well-charactercalcineurin transgenics contained extensive, primarily ized mechanism of action of calcineurin in T cells, and interstitial, deposits of collagen, as revealed by tri-NF-AT was able to synergize with GATA4 and calcineurin chrome staining ( Figure 5H ). In foci with marked fibrosis, to activate the BNP promoter in cultured cardiomyomyofiber degeneration was evident. cytes, it was formally possible that the hypertrophic response to calcineurin in vivo could involve a NF-ATindependent mechanism. To determine whether actiActivation of the Molecular Response to Hypertrophy In Vivo by Calcineurin vated NF-AT3 could substitute for all upstream elements in the hypertrophic signaling cascade, we created a We used a quantitative dot blot assay to examine RNA from hearts of calcineurin transgenic and nontransgenic constitutively active NF-AT3 mutant by deleting the N-terminal regulatory domain. This mutant, referred to littermates to determine whether activated calcineurin induced changes in cardiac gene expression characteras NF-AT3⌬317, lacked the first 317 amino acids of the protein but retained the Rel homology and transactivaistic of hypertrophy and heart failure. Consistent with reactivation of the fetal program of gene expression, tion domains ( Figure 7A ). When NF-AT3⌬317 was expressed in transfected car-␤-MHC, ␣-skeletal actin, and BNP transcripts were dramatically up-regulated in transgenic hearts, whereas diomyocytes, it became constitutively localized to the nucleus, in contrast to the wild-type protein, which re-␣-MHC was down-regulated ( Figure 6 ). Transcripts for sarcoplasmic reticulum Ca 2ϩ -ATPase (SERCA) and phosquired calcineurin signaling for nuclear localization (Figures 7B and 7C) . The NF-AT3⌬317 mutant also activated pholamban (PLB) have been shown previously to be Total RNA was isolated from hearts of control and ␣-MHC-calcineurin transgenic mice at 6 weeks of age. The indicated transcripts were detected by dot blot analysis, and their levels in transgenic hearts relative to controls are shown.
the NF-AT-dependent reporter construct in transient transfection assays (data not shown). We therefore expressed this mutant in the hearts of transgenic mice, under control of the ␣-MHC promoter. Three independent founder transgenic mice were obtained, and all showed pronounced left and right ventricular concentric hypertrophy ( Figures 7D and 7E ). Like the calcineurin transgenics, the ventricular walls of the NF-AT3⌬317 transgenics showed extensive fibrosis, with myofiber disarray and cardiomyocyte enlargement. In contrast, were stained with anti-NF-AT antibody. NF-AT3 is localized to the cytoplasm whereas NF-AT3⌬317 is localized to the nucleus.
Prevention of Cardiac Hypertrophy with CsA (D and E) Hearts from nontransgenic and NF-AT3⌬317 littermates
To begin to determine whether inhibition of calcineurin at 4 weeks of age were sectioned longitudinally and stained with H activity in vivo might be an effective means of preventing and E. La, left atrium; lv, left ventricle; ra, right atrium; rv, right cardiac hypertrophy, we tested whether subcutaneous injection of CsA could prevent cardiac dysfunction in calcineurin transgenic mice. For these experiments, we myofiber disarray and scattered cells with prominent used eight transgenic littermates from a litter of transhyperchromatic nuclei. Whether these represent cells genic mouse #37 (see Table 1 ). Four transgene-positive that were already hypertrophic at the time CsA adminisoffspring were injected twice daily with CsA (25 mg/kg tration was initiated or whether there are a few cells that body weight) and four were injected with vehicle alone.
escaped the effects of CsA will require further investigaFour nontransgenic littermates were also treated with tion. Nevertheless, CsA treatment prevented gross carCsA to control for potential toxic effects or cardiac abdiac hypertrophy and associated pathology in response normalities induced by CsA. CsA treatment was initiated to activated calcineurin in vivo. at 9 days of age and animals were sacrificed 16 days later. As shown in Figure 8 , the hearts of vehicle-treated Discussion animals were highly hypertrophic and dilated by day 25, whereas those from CsA-treated littermates were not Our results define an intracellular pathway for induction significantly different in size from nontransgenic conof cardiac hypertrophy that links Ca 2ϩ signaling in the trols. The mean heart-to-body weight ratios for calcytoplasm with changes in cardiac gene expression. cineurin transgenics were nearly 3-fold larger than those Activation of this hypertrophic pathway either in the of CsA-treated transgenics and nontransgenics. CsA cytoplasm or in the nucleus, with activated forms of treatment also prevented fibrosis of the hearts of calcalcineurin or NF-AT3, respectively, results in molecular cineurin transgenics (data not shown).
and pathophysiologic changes in the hearts of transAt a cellular level, the hypertrophic response of cardiogenic mice that mimic those associated with cardiac myocytes in the calcineurin transgenics was largely inhibited by CsA, although there were isolated areas of hypertrophy and heart failure in humans. Table  1 ) were injected subcutaneously twice daily with CsA or vehicle alone beginning at 9 days of age. At 25 days of age, animals were sacrificed and hearts were removed and sectioned longitudinally. Calcineurin, a Ca 2؉ -Sensitive Regulator mediator of cardiac hypertrophy in response to calcineurin activation.
(1) NF-AT activity was induced by of Hypertrophy It is well established that elevation in intracellular Ca 2ϩ treatment of cardiomyocytes with AngII and PE. This induction was blocked by CsA and FK 506, indicating is associated with the initiation of mechanical or agonistinduced cardiac hypertrophy (Marban et al., 1987; Bus- that it is calcineurin-dependent. (2) NF-AT3 synergized with GATA4 to activate the BNP promoter in cardiomyotamante et al., 1991; Le Guennec et al., 1991; Saeki et al., 1993; Peurreault et al., 1994; Hongo et al., 1995) .
cytes. (3) Expression of activated NF-AT3 in the heart was sufficient to bypass all upstream elements in the Remarkably, however, the possibility that calcineurin might participate in the transduction of hypertrophic hypertrophic signaling pathway and evoke a hypertrophic response. signals in cardiomyocytes has not been addressed.
Calcineurin is a ubiquitously expressed serine/threonine phosphatase that exists as a heterodimer, comCombinatorial Interactions between GATA and NF-AT Proteins prised of a 59 kDa calmodulin-binding catalytic A subunit and a 19 kDa Ca 2ϩ -binding regulatory B subunit Our results demonstrate that the C-terminal portion of the Rel homology domain of NF-AT3 interacts with the (Stemmer and Klee, 1994; Su et al., 1995) . Calcineurin is uniquely suited to mediate the prolonged hypertrophic second zinc finger of GATA4, as well as with GATA5 and GATA6, which are also expressed in the heart. The response of a cardiomyocyte to Ca 2ϩ signaling because the enzyme is activated by a sustained Ca 2ϩ plateau crystal structure of the DNA binding region of NF-ATc has revealed that the C-terminal portion of the Rel hoand is insensitive to transient Ca 2ϩ fluxes such as occur in response to cardiomyocyte contraction (Dolmetsch mology domain projects away from the DNA-binding site and also mediates interaction with AP-1 in immune et al., 1997).
Activation of calcineurin is mediated by binding of cells (Wolfe et al., 1997) .
What is the significance of the NF-AT3-GATA4 interacCa 2ϩ and calmodulin to the regulatory and catalytic subunits, respectively. Previous studies showed that overtion for activation of the hypertrophic response? Cooperative activation of the BNP promoter by NF-AT3 and expression of calmodulin in the heart also results in hypertrophy, but the mechanism involved was not deter-GATA4 requires NF-AT binding to a target sequence in the BNP upstream region. Previous studies have demmined (Gruver et al., 1993) . Our results suggest that calmodulin acts through the calcineurin pathway to inonstrated that GATA4 binding sites located near the proximal BNP promoter are also required for activation duce the hypertrophic response.
In T cells, many of the changes in gene expression of the gene (Grepin et al., 1994) . Thus, on this specific hypertrophic-responsive gene, and perhaps others, these in response to calcineurin activation are mediated by members of the NF-AT family of transcription factors, factors act combinatorially to activate transcription. NF-AT proteins regulate certain T cell genes by binding a which translocate to the nucleus following dephosphorylation by calcineurin. Three independent observations composite DNA sequence in conjunction with AP-1 (Wolfe et al., 1997) . In the case of the BNP promoter, support the conclusion that NF-AT is also an important we have no evidence for this type of joint DNA binding between GATA4 and NF-AT3, since the binding sites for these factors are not immediately adjacent and sites for both factors are required for synergistic activation. Moreover, in DNA binding assays, we have found no evidence for binding of GATA4 and NF-AT3 together to either type of site (data not shown).
A variety of transcription factors have been implicated in cardiac hypertrophy, including TEF-1 (Kariya et al., 1994; Karns et al., 1995) , SRF Sadoshima et al., 1993) , AP-1 ( Kovacic-Milivojevic et al., 1996) , and GATA4 (Hasegawa et al., 1997; Herzig et al., 1997) . In light of the cooperation between NF-AT and AP-1 in the control of T cell gene expression, it is tempting to speculate that a similar mechanism could regulate certain cardiac genes in response to hypertro- of interest to determine whether these two families of mobilization, or PKC activation (Emmel et al., 1989) . transcription factors can interact in these cells.
Thus, its ability to abrogate the hypertrophic responses of AngII and PE suggests that calcineurin activation is A Transcriptional Pathway for Cardiac Hypertrophy an essential step in the AngII and PE signal transduction Previous studies have demonstrated important roles for pathways. Ras, MAP kinase, and PKC signaling pathways in the Our results are consistent with a molecular pathway hypertrophic response. All of these signal transduction for cardiac hypertrophy as shown in Figure 9 . According pathways are associated with an inotropic increase in to this model, hypertrophic stimuli such as AngII and intracellular Ca 2ϩ concentration. In T cells, the calcineu-PE, which lead to an elevation of intracellular Ca 2ϩ , result rin signaling pathway is activated independently of, but in activation of calcineurin. NF-AT3 within the cytoplasm is integrated with, the Ras/MAP kinase and PKC pathis dephosphorylated by calcineurin, enabling it to transways. Full induction of IL-2 transcription requires colocate to the nucleus where it can interact with GATA4. stimulation via the calcineurin and Ras pathways, which While calcineurin is essential for AngII-and PE-depenresult in activation of NF-AT and AP-1, respectively, dent hypertrophy in vitro, and activation of either caland their convergence on a common downstream target cineurin or NF-AT3 is sufficient to evoke the hypersequence (reviewed in . This type of trophic response in vivo, it is also conceivable that integrated signaling bears obvious similarities to the calcineurin could act through an NF-AT-independent mechanisms for induction of cardiac hypertrophy. While mechanism to regulate hypertrophy. Indeed, calcineuour results demonstrate that the calcineurin-NFAT3 sigrin could potentially have other substrates in cardionaling pathway is sufficient to induce hypertrophy in myocytes that play regulatory roles in Ca 2ϩ handling or vivo, it also seems likely that this pathway and the Ras/ transcriptional control. NF-AT3 could also potentially MAP kinase pathway may be interdependent in cardioactivate some hypertrophic responsive genes, through myocytes, as in immune cells.
mechanisms independent of GATA4. This model also CsA and FK 506 bind the immunophilins cyclophilin predicts that phosphorylation of the N-terminal regulaand FK 506-binding protein (FKBP12), respectively, tory sites in NF-AT3 could be a key regulatory step in forming complexes that bind the calcineurin catalytic the hypertrophic signaling pathway. By inference, actisubunit and inhibit its activity. Our results show that vation of the NF-AT kinase would be expected to interCsA and FK 506 block the ability of cultured cardiomyofere with hypertrophy, whereas its inhibition would lead cytes to undergo hypertrophy in response to AngII and to hypertrophy. PE. Both of these hypertrophic agonists have been These studies also raise the possibility that an NFshown to act by elevating intracellular Ca 2ϩ , which results in activation of the PKC and MAP kinase signaling AT-dependent mechanism could control normal cardiac The results of this study raise the possibility that calci-
The rescued NF-AT3 cDNA fragment was also subcloned as a neurin activation may regulate hypertrophy in response
XhoI fragment into the SalI site of the mammalian GAL4 fusion to a variety of pathologic stimuli and suggest a sensing plasmid pM1 and tested for activation of the GAL4-dependent remechanism for altered sarcomeric function. Of note, porter. Methods for culturing and transfection of 10T1/2 cells along with the analysis of CAT activity were described previously (Molken- there are several familial hypertrophic cardiomyopathies tin et al., 1996) .
(FHC) caused by mutations in contractile protein genes, which result in subtle disorganization in the fine crystal-
In Vitro Translation and Immunoprecipitation
line-like structure of the sarcomere (Watkins et al., 1995;  The partial NF-AT3 cDNA region rescued from the two-hybrid prey Vikstrom and Leinwand, 1996) . It is unknown how sarco- with cardiac hypertrophy and heart failure.
XbaI fragments corresponding to the denoted amino acids in GATA4
The ␣-MHC-calcineurin transgenic mice also represent were subcloned to generate pCite2A-GATA4 80-441, pCite2A-a model in which to investigate the potential reversibility tricular ejection fraction and results in fewer ischemic episodes (Reid and Yacoub, 1988) . Given the remarkable
Preparation of Primary Rat Cardiomyocytes
Cardiomyocyte cultures were prepared by dissociation of 1-daysimilarity between the molecular and pathophysiologiold neonatal rat hearts and were differentially plated to remove cal responses of the heart in calcineurin transgenic fibroblasts. To induce the hypertrophic response, AngII and PE were mice and in human heart failure, these transgenic mice added to cardiomyocyte cultures at 10 nM and 10 M, respectively, should be a useful model for drug discovery and for in serum-free M199 media. The culture media containing either agoidentifying additional genes that influence the hypertronist was changed every 12 hr for a period of 72 hr. CsA and FK 506 phic response.
were present at 500 ng/ml and 150 ng/ml, respectively, over the entire 72 hr culturing period. To analyze effects of these agents on NF-AT3 activity, an NF-AT-dependent reporter was transfected into Experimental Procedures cardiomyocytes by Ca 2ϩ phosphate transfection in M199 serumfree media. Cardiomyocytes were then cultured for 72 hr with the Two-Hybrid Screens identified agent. The NF-AT-dependent reporter contained three NFThe GATA4 bait used for the yeast two-hybrid screen contained AT binding sites from the IL-2 promoter cloned upstream of the amino acids 130-409 fused in-frame with the GAL4 DNA-binding thymidine kinase minimal promoter and the luciferase gene (gift from domain. This region of GATA4 encompasses the two zinc finger T. Hoey). Methods of preparation for cellular extracts and luciferase domains and was encoded within a PstI-NsiI fragment, which was assays have been described . cloned into a Pst I site in the pAS yeast expression vector. pAS-GATA4 was cotransformed into yeast with an embryonic 10.5 mouse cDNA library that contained the GAL4 activation domain fused to
Gel Mobility Shift Assays and Mutagenesis
To identify potential NF-AT binding sites within the BNP promoter, random cDNAs. From over 5 million primary colonies screened, approximately 100 positive colonies were identified. From each indigel mobility shift assays were performed with double-stranded oligonucleotides corresponding to putative sites located at Ϫ927, vidual colony, the activating plasmid was rescued and the cDNA insert was sequenced. Clones containing cDNA inserts in the anti-Ϫ327, and Ϫ27, relative to the transcription start site (Owaga et al., 1995), or the consensus site from the IL-2 promoter. Sequences of sense orientation or out-of-frame were discarded. The remaining probes were as follows: BNP-927: 5Ј-CTATCCTTTTGTTTTCCATC Acknowledgments CTG-3Ј; BNP-327: 5Ј-TCCCTGCCTTTTCCAGCAACGGT-3Ј; BNP-27: 5Ј-GCTCCAGGATAAAAGGCCACGGT-3Ј; IL-2: 5Ј-TACATTGGAAAA This work was supported by grants from NIH to E. N. O. and from the American Heart Association to S. R. G. J. D. M. was supported TTTTATTACAC-3Ј. For gel mobility shift assays utilizing the NF-AT3 Rel homology domain, 2 l of a coupled in vitro transcription-translaby an NIH postdoctoral fellowship at UT Southwestern. We are grateful to the following individuals for reagents: T. Hoey, Y. Ogawa, tion reaction (TNT Kit, Promega, Madison, WI) was incubated with the indicated oligonucleotide probe (40,000 cpm of a 32 P-labeled S. O'Keefe, and N. Rice. We also thank Chuanzhen Wu and Brian Mercer for generating transgenic mice, A. Tizenor for assistance probe per reaction) in the presence of 1 g of poly (dI-dC) for 20 min at room temperature, followed by nondenaturing electrophoresis.
with graphics, Robert Webb for histology, and our colleagues in the Olson lab for advice and encouragement. Unlabeled competitor oligonucleotides were added at a 100-fold molar excess, and 2 l of NF-AT3-specific antiserum (Gift from N. Rice; Lyakh et al., 1997) was added for the supershift experiments.
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